An experimental pill has shown encouraging results in patients with advanced pancreatic cancer, offering fresh hope for improved treatment of one of the world’s deadliest cancers. Researchers reported on Sunday that the drug, called daraxonrasib, helped patients live longer by targeting a genetic mutation responsible for driving tumour growth in the vast majority of pancreatic Read More…
